Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300127 · ClinicalTrials.gov registry record · Early Phase 1
Pioglitazone for Idiopathic Gastroparesis
A Early Phase 1 study of Gastroparesis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04300127: Completed Early Phase 1 study of Gastroparesis, sponsored by Johns Hopkins University.
NCT04300127 is a Early Phase 1 study of Gastroparesis that has completed, run by Johns Hopkins University. The registered enrollment target is 14 participants, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04300127, a Early Phase 1 study of Gastroparesis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The principal objective of this pilot study will be to evaluate whether 8 weeks of treatment of pioglitazone will improve symptoms as measured by the Gastrointestinal Symptom Index (GCSI) in patients with Idiopathic Gastroparesis.
Conditions Studied
Interventions
- DRUG Pioglitazone 30 mg
Study Locations (1)
Maryland
- Johns Hopkins Bayview Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2025-03-18 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04300127
The ClinicalTrials.gov registry entry for NCT04300127 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 44 other Gastroparesis trials with a reported enrollment target (95% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Pioglitazone 30 mg is the first listed.
NCT04300127 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04300127 about?
NCT04300127 is a clinical study titled "Pioglitazone for Idiopathic Gastroparesis". The principal objective of this pilot study will be to evaluate whether 8 weeks of treatment of pioglitazone will improve symptoms as measured by the Gastrointestinal Symptom Index (GCSI) in patients with Idiopathic Gastroparesis.
What is the current status of trial NCT04300127?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2019-10-24. Estimated completion is 2025-03-18.
What conditions does trial NCT04300127 study?
This clinical trial studies the following conditions: Gastroparesis.
What interventions are being tested in trial NCT04300127?
The interventions under investigation include: Pioglitazone 30 mg (DRUG).
Who is sponsoring clinical trial NCT04300127?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04300127 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Growth Hormone for the Treatment of Gastroparesis
RECRUITING · Early Phase 1
-
Gastroparesis Registry 4
RECRUITING
-
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
RECRUITING · NA
-
Study of Gastric Motility in Eosinophilic Gastritis
RECRUITING
-
Indiana University Gastrointestinal Motility Diagnosis Registry
RECRUITING
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.